Reduction of daunomycin toxicity by razoxane
Open Access
- 31 May 1981
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 43 (6), 871-877
- https://doi.org/10.1038/bjc.1981.127
Abstract
A single dose of 200 mg/kg razoxane protected mice against the subchronic lethal effects (i.e. within 21 days) of 10 mg/kg daunomycin. When the razoxane dose was split into 2 doses of 100 mg/kg, even better protection against higher doses of daunomycin was obtained. The best protective effect was seen when the razoxane was given 24 h before or simultaneously with the daunomycin, and it was still present, though less, 24 h later. Histopathological examination to determine the site of protection showed it to be in the small bowel. Marrow and cardiac tissue showed no evident changes when examined by light microscopy.Keywords
This publication has 5 references indexed in Scilit:
- REDUCTION OF DAUNORUBICIN LETHALITY AND MYOCARDIAL CELLULAR ALTERATIONS BY PRETREATMENT WITH ICRF-187 IN SYRIAN GOLDEN-HAMSTERS1979
- PHASE-II STUDY WITH SEQUENTIAL L-ASPARAGINASE AND METHOTREXATE IN ADVANCED REFRACTORY BREAST-CANCER1979
- Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamideBritish Journal of Cancer, 1978
- Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).1975
- Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943)Toxicology and Applied Pharmacology, 1974